Biomarker-driven mechanisms and therapeutic targets for prostate diseases through mendelian randomization and molecular docking
This study provides genetic evidence linking biomarkers to prostate diseases and identifies novel druggable targets and repurposing opportunities, offering mechanistic insights and prospects for precision therapy.
Authors
- Haiqiang Pan
- Xiu Gong (ORCID: https://orcid.org/0000-0002-0752-7345)
- Songsong Meng (ORCID: https://orcid.org/0000-0002-9533-7372)
- Xin Luo (ORCID: https://orcid.org/0000-0002-1348-5305)
- Junyi Zhang (ORCID: https://orcid.org/0009-0000-2310-0053)
- Junxiao Shen (ORCID: https://orcid.org/0000-0002-1552-4689)
- Zhijie Chen (ORCID: https://orcid.org/0000-0003-0627-0856)
- Yixiong Zheng
- Luyuan Lu
Institutions
- Zhejiang International Studies University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- The Aging Male
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1080/13685538.2025.2578633
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52